A Microfluidic Channel Method for Rapid Drug-Susceptibility Testing of Pseudomonas aeruginosa

• Published in: PloS one Vol. 11; no. 2; p. e0148797
• Main Authors: Matsumoto, Yoshimi, Sakakihara, Shouichi, Grushnikov, Andrey, Kikuchi, Kazuma, Noji, Hiroyuki, Yamaguchi, Akihito, Iino, Ryota, Yagi, Yasushi, Nishino, Kunihiko
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 12.02.2016; Public Library of Science (PLoS)
• Subjects: Accelerated tests; Amikacin; Amikacin - pharmacology; Anti-Bacterial Agents - pharmacology; Antibiotic resistance; Antibiotics; Antimicrobial agents; Automation; Bacteria; Biology and Life Sciences; Ceftazidime; Ceftazidime - pharmacology; Cell division; Cell size; Channels; Chemical compounds; Ciprofloxacin; Ciprofloxacin - pharmacology; Dilution; Drug resistance; Drug Resistance, Multiple, Bacterial; Drugs; Elongation; Engineering and Technology; Escherichia coli - drug effects; Identification; Identification methods; Industrial research; Instrumentation; Lab-On-A-Chip Devices; Mass spectrometry; Medical screening; Medicine and Health Sciences; Meropenem; Methods; Microbial drug resistance; Microbial sensitivity tests; Microbial Sensitivity Tests - methods; Microfluidics; Microscopy; Mycobacterium tuberculosis; Nosocomial infections; Pathogens; Pharmacology; Physiological aspects; Piperacillin; Piperacillin - pharmacology; Properties; Pseudomonas aeruginosa; Pseudomonas aeruginosa - drug effects; Pseudomonas aeruginosa - growth & development; Research and Analysis Methods; Scientific imaging; Staphylococcus aureus; Studies; Thienamycins - pharmacology; Tuberculosis; Japan
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0148797

The recent global increase in the prevalence of antibiotic-resistant bacteria and lack of development of new therapeutic agents emphasize the importance of selecting appropriate antimicrobials for the treatment of infections. However, to date, the development of completely accelerated drug susceptibility testing methods has not been achieved despite the availability of a rapid identification method. We proposed an innovative rapid method for drug susceptibility testing for Pseudomonas aeruginosa that provides results within 3 h. The drug susceptibility testing microfluidic (DSTM) device was prepared using soft lithography. It consisted of five sets of four microfluidic channels sharing one inlet slot, and the four channels are gathered in a small area, permitting simultaneous microscopic observation. Antimicrobials were pre-introduced into each channel and dried before use. Bacterial suspensions in cation-adjusted Mueller-Hinton broth were introduced from the inlet slot and incubated for 3 h. Susceptibilities were microscopically evaluated on the basis of differences in cell numbers and shapes between drug-treated and control cells, using dedicated software. The results of 101 clinically isolated strains of P. aeruginosa obtained using the DSTM method strongly correlated with results obtained using the ordinary microbroth dilution method. Ciprofloxacin, meropenem, ceftazidime, and piperacillin caused elongation in susceptible cells, while meropenem also induced spheroplast and bulge formation. Morphological observation could alternatively be used to determine the susceptibility of P. aeruginosa to these drugs, although amikacin had little effect on cell shape. The rapid determination of bacterial drug susceptibility using the DSTM method could also be applicable to other pathogenic species, and it could easily be introduced into clinical laboratories without the need for expensive instrumentation.